Document is current
Any future updates will be listed below
-
Authors
El Harake, Lamis
Samhan, Ashraf
Cremer, Paul C.
Al Kazaz, Mohamed
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 1 November 2025
First Online: 21 January 2026
Declarations
:
: Lamis El Harake has no disclosures to report. Ashraf Samhan has no disclosures to report. Al-Kazaz: Research grants from Kiniksa Pharmaceuticals, Ventyx BioSciences, and Cardiol Therapeutics; speaking honoraria from Kiniksa Pharmaceuticals; and consulting fees from Edwards Lifesciences. Cremer: Consulting fees from Kiniksa Pharmaceuticals, CardiolRx, Ventyx Biosciences, Monte Rosa Therapuetics, Pfizer, Boston Scientific, and General Electric.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.
